近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Cao X#, Wen ZS#, Wang XD, Li Y, Liu KY, Wang X: The clinical effect of metformin on survival of lung cancer patients with diabetes: A comprehensive systematic review and meta-analysis of retrospective studies. Journal of cancer 2017, 8(13):2532-2541. 2.Chen YF, Xie JD, Jiang YC, Chen DT, Pan JH, Chen YH, Yuan YF, Wen ZS*, Zeng WA*: The prognostic value of peripheral benzodiazepine receptor in paitents with esophageal squamous cell carcinoma. Journal of cancer 2017, 8(16):3343-3355. 3.Cao X, Zhong JD, Yang TZ, Jiang YC, Wen ZS*: Do male esophageal cancer patients have impaired sexual function after seophagectomy? A self-reported outcomes study. Quality of life research 2017, 26:3331-3341. 4.Yang M, Chen D, Gao X, Wen Z*: A case report of giant esophageal neurofibroma. Journal of thoracic disease 2017, 9(9):E757-E761. 5.Chen YF, Li Q, Chen DT, Pan JH, Chen YH, Wen ZS*, Zeng WA*: Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy. Cancer biomarkers 2016, 17(1):89-96. 6.Huang ZL, Cao X, Luo RZ, Chen YF, Zhu LC, Wen ZS*: Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study. Oncology letters 2016, 11(1):299-305. 7.Wei MM#, Zhou YC#, Wen ZS#, Zhou B, Huang YC, Wang GZ, Zhao XC, Pan HL, Qu LW, Zhang J et al: Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis. Oncotarget 2016, 7(37):59556-59571. 8.Pan HL#, Wen ZS#, Huang YC, Cheng X, Wang GZ, Zhou YC, Wang ZY, Guo YQ, Cao Y, Zhou GB: Down-regulation of microRNA-144 in air pollution-related lung cancer. Scientific reports 2015, 5:14331. 9.Cao X, Li Y, Luo RZ, Zhang L, Zhang SL, Zeng J, Han YJ, Wen ZS*: Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients. Scientific reports 2015, 5:8230 10.Cao X, Chen YZ, Luo RZ, Zhang L, Zhang SL, Zeng J, Jiang YC, Han YJ, Wen ZS*: Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Oncotarget 2015, 6(13):11704-11713 11.Huang ZL, Lin ZR, Xiao YR, Cao X, Zhu LC, Zeng MS, Zhong Q, Wen ZS*: High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis. Oncotarget 2015, 6(9):6850-6861. 12.Cao X#, Wen ZS#, Sun YJ, Li Y, Zhang L, Han YJ: Prognostic value of ABO blood group in patients with surgically resected colon cancer. British journal of cancer 2014, 111(1):174-180. 13.Liu Z#, Ma L#, Wen ZS#, Cheng YX, Zhou GB: Ethoxysanguinarine induces inhibitory effects and downregulates CIP2A in lung cancer cells. ACS medicinal chemistry letters 2014, 5(2):113-118. 14.Chen YF, Ma G, Cao X, Huang ZL, Zeng MS, Wen ZS*: Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma. Medical oncology 2014, 31(12):317. 15.Chen YF, Ma G, Cao X, Luo RZ, He LR, He JH, Huang ZL, Zeng MS, Wen ZS*: Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma. BMC surgery 2013, 13:15. 16.Wang LC#, Wen ZS#, Qiu YT, Chen XQ, Chen HB, Wei MM, Liu Z, Jiang S, Zhou GB: Largazole arrests cell cycle at G1 phase and triggers proteasomal degradation of E2F1 in lung cancer cells. ACS medicinal chemistry letters 2013, 4(10):921-929. 17.Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS*: Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. The Annals of thoracic surgery 2012, 93(5):1674-1680. 18.Cao X, Han Y, He L, Xiang J, Wen Z*: Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment? Oral oncology 2011, 47(8):747-752. 19.Cao X, He LR, Xie FY, Chen YF, Wen ZS*: Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit? BMC cancer 2011, 11:370. 20.Cao X, Luo RZ, He LR, Li Y, Lin WQ, Chen YF, Wen ZS*: Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis. Radiation oncology 2011, 6:104.
京公网安备 11010802027423号